Literature DB >> 30696986

The effects of neuroblastoma and chemotherapy on metabolism, fecal microbiome, volatile organic compounds, and gut barrier function in a murine model.

Christoph Castellani1, Georg Singer2, Margarita Eibisberger1, Beate Obermüller3, Gert Warncke1, Wolfram Miekisch4, Dagmar Kolb-Lenz5, Gregor Summer1, Theresa M Pauer1, Ahmed ElHaddad1, Karl Kashofer6, Holger Till1.   

Abstract

BACKGROUND: Following transplantation of human neuroblastoma (NB) cells into athymic mice, we investigated the effects of tumor growth and cyclophosphamide (CTX) treatment on systemic metabolism, gut inflammation and permeability, fecal microbiome and volatile organic compounds (VOCs).
METHODS: NB cells (MHH-NB11) were implanted into athymic mice (n=20); 20 healthy mice served as controls (sham).  CTX was given to 20 animals (10 NB and 10 sham) after 8 and 9 weeks. Metabolic changes were measured. Ileum samples were obtained for RT-PCR (claudins 2 and 4, occludin, tight junction protein 1) and apoptosis rate determination. Fecal microbiome and VOCs were analyzed. Values were compared to sham animals.
RESULTS: NB caused reduction of adipose tissue, increases of IL-6 and TNF-α, and decreases of TGF-β1 and -β2. Serum FITC-dextrane levels were increased in NB and improved under CTX. Claudin 4 expression was higher in NB versus NB + CTX and sham animals. NB caused increased apoptosis of epithelial cells. NB but also CTX led to a reduction in the abundance of Lactobacillus. NB led to alterations of the fecal VOC profile.
CONCLUSIONS: NB caused a catabolic pro-inflammatory state, increased gut permeability, altered fecal VOCs and reductions of Lactobacillus. Further investigations are required to determine if modifications of the intestinal microbiome may reverse some of the observed effects.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30696986     DOI: 10.1038/s41390-019-0283-1

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  3 in total

Review 1.  Mucosal immunity and inflammation. V. Innate mechanisms of mucosal defense and repair: the best offense is a good defense.

Authors:  D K Podolsky
Journal:  Am J Physiol       Date:  1999-09

2.  A guide to histomorphological evaluation of intestinal inflammation in mouse models.

Authors:  Ulrike Erben; Christoph Loddenkemper; Katja Doerfel; Simone Spieckermann; Dirk Haller; Markus M Heimesaat; Martin Zeitz; Britta Siegmund; Anja A Kühl
Journal:  Int J Clin Exp Pathol       Date:  2014-07-15

3.  Release of volatile organic compounds from the lung cancer cell line NCI-H2087 in vitro.

Authors:  Andreas Sponring; Wojciech Filipiak; Tomas Mikoviny; Clemens Ager; Jochen Schubert; Wolfram Miekisch; Anton Amann; Jakob Troppmair
Journal:  Anticancer Res       Date:  2009-01       Impact factor: 2.480

  3 in total
  2 in total

1.  The Effects of Prebiotic Supplementation with OMNi-LOGiC® FIBRE on Fecal Microbiome, Fecal Volatile Organic Compounds, and Gut Permeability in Murine Neuroblastoma-Induced Tumor-Associated Cachexia.

Authors:  Beate Obermüller; Georg Singer; Bernhard Kienesberger; Ingeborg Klymiuk; Daniela Sperl; Vanessa Stadlbauer; Angela Horvath; Wolfram Miekisch; Peter Gierschner; Reingard Grabherr; Hans-Jürgen Gruber; Maria D Semeraro; Holger Till; Christoph Castellani
Journal:  Nutrients       Date:  2020-07-08       Impact factor: 5.717

Review 2.  Cancer predictive studies.

Authors:  Ivano Amelio; Riccardo Bertolo; Pierluigi Bove; Eleonora Candi; Marcello Chiocchi; Chiara Cipriani; Nicola Di Daniele; Carlo Ganini; Hartmut Juhl; Alessandro Mauriello; Carla Marani; John Marshall; Manuela Montanaro; Giampiero Palmieri; Mauro Piacentini; Giuseppe Sica; Manfredi Tesauro; Valentina Rovella; Giuseppe Tisone; Yufang Shi; Ying Wang; Gerry Melino
Journal:  Biol Direct       Date:  2020-10-14       Impact factor: 4.540

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.